These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 17959327)

  • 1. Clinical efficacy of zonisamide in Lennox-Gastaut syndrome: Korean multicentric experience.
    You SJ; Kang HC; Kim HD; Lee HS; Ko TS
    Brain Dev; 2008 Apr; 30(4):287-90. PubMed ID: 17959327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of adjunctive therapy with zonisamide in childhood intractable epilepsy.
    Lee YJ; Kang HC; Seo JH; Lee JS; Kim HD
    Brain Dev; 2010 Mar; 32(3):208-12. PubMed ID: 19304420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term efficacy and safety of monotherapy and adjunctive therapy with zonisamide.
    Tosches WA; Tisdell J
    Epilepsy Behav; 2006 May; 8(3):522-6. PubMed ID: 16542880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and prognosis of a short course of prednisolone therapy for pediatric epilepsy.
    You SJ; Jung DE; Kim HD; Lee HS; Kang HC
    Eur J Paediatr Neurol; 2008 Jul; 12(4):314-20. PubMed ID: 17951084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of zonisamide monotherapy in a cohort of children with epilepsy.
    Kothare SV; Kaleyias J; Mostofi N; Valencia I; Melvin JJ; Hobdell E; Khurana DS; Legido A
    Pediatr Neurol; 2006 May; 34(5):351-4. PubMed ID: 16647993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zonisamide monotherapy for epilepsy in children and young adults.
    Wilfong AA
    Pediatr Neurol; 2005 Feb; 32(2):77-80. PubMed ID: 15664764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy.
    Shinnar S; Pellock JM; Conry JA
    Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of zonisamide in idiopathic generalized epilepsy.
    Marinas A; Villanueva V; Giráldez BG; Molins A; Salas-Puig J; Serratosa JM
    Epileptic Disord; 2009 Mar; 11(1):61-6. PubMed ID: 19264587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy.
    Kothare SV; Valencia I; Khurana DS; Hardison H; Melvin JJ; Legido A
    Epileptic Disord; 2004 Dec; 6(4):267-70. PubMed ID: 15634623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized, controlled clinical trial of zonisamide as adjunctive treatment for refractory partial seizures.
    Sackellares JC; Ramsay RE; Wilder BJ; Browne TR; Shellenberger MK
    Epilepsia; 2004 Jun; 45(6):610-7. PubMed ID: 15144425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical prescribing and long-term efficacy and safety of zonisamide.
    Leppik IE
    Epilepsy Res; 2006 Feb; 68 Suppl 2():S17-24. PubMed ID: 16406743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and tolerability of rufinamide in children and adults with refractory epilepsy: first European experience.
    Kluger G; Kurlemann G; Haberlandt E; Ernst JP; Runge U; Schneider F; Makowski C; Boor R; Bast T
    Epilepsy Behav; 2009 Mar; 14(3):491-5. PubMed ID: 19162229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zonisamide in the management of epilepsy--Japanese experience.
    Ohtahara S
    Epilepsy Res; 2006 Feb; 68 Suppl 2():S25-33. PubMed ID: 16321507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A long-term follow-up of zonisamide monotherapy.
    Fukushima K; Seino M
    Epilepsia; 2006 Nov; 47(11):1860-4. PubMed ID: 17116025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term use of zonisamide in refractory childhood-onset epilepsy.
    Kluger G; Zsoter A; Holthausen H
    Eur J Paediatr Neurol; 2008 Jan; 12(1):19-23. PubMed ID: 17574461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of corpus callosotomy and vagus nerve stimulation in children with Lennox-Gastaut syndrome.
    You SJ; Kang HC; Ko TS; Kim HD; Yum MS; Hwang YS; Lee JK; Kim DS; Park SK
    Brain Dev; 2008 Mar; 30(3):195-9. PubMed ID: 17825516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vagus nerve stimulation for refractory epilepsy in children: More to VNS than seizure frequency reduction.
    Shahwan A; Bailey C; Maxiner W; Harvey AS
    Epilepsia; 2009 May; 50(5):1220-8. PubMed ID: 19170732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term safety and efficacy of zonisamide in patients with refractory partial-onset epilepsy.
    Wroe SJ; Yeates AB; Marshall A
    Acta Neurol Scand; 2008 Aug; 118(2):87-93. PubMed ID: 18547272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenocorticotropic hormone versus pulsatile dexamethasone in the treatment of infantile epilepsy syndromes.
    Haberlandt E; Weger C; Sigl SB; Rauchenzauner M; Scholl-Bürgi S; Rostásy K; Karall D
    Pediatr Neurol; 2010 Jan; 42(1):21-7. PubMed ID: 20004858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience with zonisamide monotherapy and adjunctive therapy in children with epilepsy at a tertiary care referral center.
    Kim HL; Aldridge J; Rho JM
    J Child Neurol; 2005 Mar; 20(3):212-9. PubMed ID: 15832611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.